Cargando…
A High Risk Group in the Modified National Institutes of Health Consensus Criteria for the Gastrointestinal Stromal Tumor: A Clear Indication of the Adjuvant Imatinib
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Korean Association for the Study of Intestinal Diseases
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204718/ https://www.ncbi.nlm.nih.gov/pubmed/25349590 http://dx.doi.org/10.5217/ir.2014.12.3.176 |
| _version_ | 1782340597634301952 |
|---|---|
| author | Chang, Dong Kyung |
| author_facet | Chang, Dong Kyung |
| author_sort | Chang, Dong Kyung |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-4204718 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Korean Association for the Study of Intestinal Diseases |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-42047182014-10-27 A High Risk Group in the Modified National Institutes of Health Consensus Criteria for the Gastrointestinal Stromal Tumor: A Clear Indication of the Adjuvant Imatinib Chang, Dong Kyung Intestinal Res Editorial Korean Association for the Study of Intestinal Diseases 2014-07 2014-07-25 /pmc/articles/PMC4204718/ /pubmed/25349590 http://dx.doi.org/10.5217/ir.2014.12.3.176 Text en © Copyright 2014. Korean Association for the Study of Intestinal Diseases. All rights reserved. http://creativecommons.org/licenses/by-nc/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. |
| spellingShingle | Editorial Chang, Dong Kyung A High Risk Group in the Modified National Institutes of Health Consensus Criteria for the Gastrointestinal Stromal Tumor: A Clear Indication of the Adjuvant Imatinib |
| title | A High Risk Group in the Modified National Institutes of Health Consensus Criteria for the Gastrointestinal Stromal Tumor: A Clear Indication of the Adjuvant Imatinib |
| title_full | A High Risk Group in the Modified National Institutes of Health Consensus Criteria for the Gastrointestinal Stromal Tumor: A Clear Indication of the Adjuvant Imatinib |
| title_fullStr | A High Risk Group in the Modified National Institutes of Health Consensus Criteria for the Gastrointestinal Stromal Tumor: A Clear Indication of the Adjuvant Imatinib |
| title_full_unstemmed | A High Risk Group in the Modified National Institutes of Health Consensus Criteria for the Gastrointestinal Stromal Tumor: A Clear Indication of the Adjuvant Imatinib |
| title_short | A High Risk Group in the Modified National Institutes of Health Consensus Criteria for the Gastrointestinal Stromal Tumor: A Clear Indication of the Adjuvant Imatinib |
| title_sort | high risk group in the modified national institutes of health consensus criteria for the gastrointestinal stromal tumor: a clear indication of the adjuvant imatinib |
| topic | Editorial |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4204718/ https://www.ncbi.nlm.nih.gov/pubmed/25349590 http://dx.doi.org/10.5217/ir.2014.12.3.176 |
| work_keys_str_mv | AT changdongkyung ahighriskgroupinthemodifiednationalinstitutesofhealthconsensuscriteriaforthegastrointestinalstromaltumoraclearindicationoftheadjuvantimatinib AT changdongkyung highriskgroupinthemodifiednationalinstitutesofhealthconsensuscriteriaforthegastrointestinalstromaltumoraclearindicationoftheadjuvantimatinib |